Cryopreserved clinical-grade human embryonic stem cell-derived dopaminergic progenitors function in Parkinson's disease models-Reference-Cited by-同舟云学术

Cryopreserved clinical-grade human embryonic stem cell-derived dopaminergic progenitors function in Parkinson's disease models

Published:2023-09 Issue: Volume:329 Page:121990
ISSN:0024-3205
Container-title:Life Sciences
language:en
Short-container-title:Life Sciences

Author:

Naderi Somayeh,Shiri Zahra,Zarei-Kheirabadi Masoumeh,Mollamohammadi Sepideh,Hosseini Parastoo,Rahimi Golnoosh,Moradmand Azadeh,Samadian Azam,Shojaei Amir,Yeganeh Meghdad,Mousavi Seyed Ahmad,Badri Motahare,Taei Adeleh,Hassani Seyedeh-Nafiseh,Baharvand Hossein

Publisher

Elsevier BV

Subject

General Pharmacology, Toxicology and Pharmaceutics,General Biochemistry, Genetics and Molecular Biology,General Medicine

Reference42 articles.

1. Parkinson’s disease: mechanisms and models;Dauer;Neuron,2003

2. Bringing advanced therapies for Parkinson’s disease to the clinic: the scientist’s perspective;Tomishima;J. Parkinsons Dis.,2021

3. Current status of stem cell-derived therapies for Parkinson’s disease: from cell assessment and imaging modalities to clinical trials;Jang;Front. Neurosci.,2020

4. Fetal dopaminergic transplantation trials and the future of neural grafting in Parkinson’s disease;Barker;Lancet Neurol.,2013

5. Extensive graft-derived dopaminergic innervation is maintained 24 years after transplantation in the degenerating parkinsonian brain;Li;Proc. Natl. Acad. Sci. U. S. A.,2016

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Human stem cell transplantation for Parkinson’s disease: A systematic review ofin situsurvival and maturation of progenitors derived from human embryonic or induced stem cells in Parkinsonian models;2024-03-31